In fact, the regulation of leptin levels is one of the key factors of the disease, given its implications in the development of obesity-associated comorbidities, such as non-alcoholic fatty liver disease (NAFLD) [41,42]. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.